Literature DB >> 31552919

Control of CRISPR-Cas9 with small molecule-activated allosteric aptamer regulating sgRNAs.

Bingqian Lin1, Yuan An1, Lingyan Meng1, Huimin Zhang2, Jia Song2, Zhi Zhu1, Wen Liu3, Yanling Song4, Chaoyong Yang4.   

Abstract

The CRISPR-Cas9 system enables facile and efficient genome engineering in living cells and organisms. Small molecule control of CRISPR-Cas9 would allow precise temporal control in applications of the technology. In this work, we developed s[combining low line]mall m[combining low line]olecule-activated allosteric a[combining low line]ptamer r[combining low line]egulat[combining low line]ing (SMART)-sgRNAs as general strategies to control programmable genome editing. With SMART-sgRNAs, temporal control of the CRISPR-Cas9 system against different targets can be achieved, which should facilitate its application in various fields, such as biomedical genome editing, drug screening and chromosome imaging.

Year:  2019        PMID: 31552919     DOI: 10.1039/c9cc05531b

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  4 in total

Review 1.  Regulating CRISPR/Cas9 Function through Conditional Guide RNA Control.

Authors:  Wes Brown; Wenyuan Zhou; Alexander Deiters
Journal:  Chembiochem       Date:  2020-11-17       Impact factor: 3.164

Review 2.  Small Molecules for Enhancing the Precision and Safety of Genome Editing.

Authors:  Siyoon Shin; Seeun Jang; Donghyun Lim
Journal:  Molecules       Date:  2022-09-23       Impact factor: 4.927

Review 3.  Riboswitches for Controlled Expression of Therapeutic Transgenes Delivered by Adeno-Associated Viral Vectors.

Authors:  Zachary J Tickner; Michael Farzan
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-10

Review 4.  Controlling CRISPR with small molecule regulation for somatic cell genome editing.

Authors:  Namita Khajanchi; Krishanu Saha
Journal:  Mol Ther       Date:  2021-06-24       Impact factor: 12.910

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.